"Patients with ovarian cancer and other deadly
tumors will regain access to an important chemotherapy drug, Food and
Drug Administration officials told USA TODAY in an exclusive interview
Monday. The
drug, Doxil, has been in short supply since last June. There are no
generic versions of the drug, which is also used to treat multiple
myeloma and AIDS-related Kaposi's sarcoma.
The
agency says it will announce today that it has worked out a deal to
temporarily import a replacement drug, called
Lipodox, from an Indian
company, says the
FDA's Sandra Kweder. The FDA has previously inspected the company, Sun Pharma Global, which exports the drug to other companies....."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.